Skip to main content
RARE logo

RARE

Ultragenyx Pharmaceutical Inc.
$33.22 -0.60 (-1.77%) At close · Jul 13
Market Cap
$3.27B
Shares
98,489,224

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
2024-02-01 $350,000,000
Key facts CIK 1515673 CUSIP 90400D108 13F (30d) 13 filings 12 filers Visit website Investor relations